SARCOMA HISTIOCÍTICO: UMA NECESSIDADE MÉDICA NÃO ATINGIDA COM DESFECHOS DESFAVORÁVEIS

Autor: JA Balthazar, JC Amarante, AL Oliveira, FD Costa, T Fischer, JS Filho, T Silveira

Publikováno v: Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S266-S267 (2024)

Introdução: O Sarcoma Histiocítico Verdadeiro (SHV) é uma neoplasia rara derivada de histiócitos, caracterizada por apresentação agressiva e respostas insatisfatórias a quimioterápicos clássicos. De acordo com a Organização Mundial da Sa�

Externí odkaz: https://doaj.org/article/8960b90e47c34a14ab939aa099557372

Integrating a Bacillus‐ based product with fungicides by foliar application to protect soybean: a sustainable approach to avoid exclusive use of chemicals

Autor: Fabio M, Santos, Laura S, Viera, Darcila P, Camargo, Marlove Fb, Muniz, Ivan Fd, Costa, Jerson Vc, Guedes, Jansen Rp, Santos, Julio Cp, Silva

Publikováno v: Pest Management Science. 78:4832-4840

Biological control is widely applied against soybean (Glycine max L.) soil-borne pathogens by furrow or seed treatments. The efficiency of bioproducts and timing of application by foliar sprays against soybean pathogens needs to be more fully underst

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ae17d83d2e3183bfe7fb503369dc2a6
https://doi.org/10.1002/ps.7104

Scaled up countercurrent chromatography separation of secondary metabolites from Schinus therebinthifolius Raddi

Autor: Gilda Guimarães Leitão, Ian Garrard, FD Costa, Gerold Jerz, Mariana Neves Vieira, Peter Winterhalter, Svetlana Ignatova

Publikováno v: Planta Medica. 79

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::109e0e272797f079bef69b69f6108a1e
https://doi.org/10.1055/s-0033-1351872

Diffuse hemispheric glioma with H3 p.K28M (K27M) mutation: Unusual non-midline presentation of diffuse midline glioma, H3 K27M-altered?

Autor: Donev K; Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, Arizona, USA., Sundararajan V; OhioHealth Riverside Methodist Hospital, Columbus, Ohio, USA.; CORPath Pathology Services, Columbus, Ohio, USA., Johnson D; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA., Balan J; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA., Chambers M; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA., Paulson VA; Department of Laboratory Medicine and Pathology, Genetics and Solid Tumor Laboratory, University of Washington, Seattle, Washington, USA., Scherpelz KP; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA., Abdullaev Z; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Quezado M; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Cimino PJ; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Pratt D; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Valerio E; Department of Pathology, A.C. Camargo Cancer Center, Sao Paulo, Brazil., Alves de Castro JV; Department of Pathology, A.C. Camargo Cancer Center, Sao Paulo, Brazil., Carraro DM; Genomics and Molecular Biology Group, International Center of Research CIPE, A.C. Camargo Cancer Center, Sao Paulo, Brazil.; National Institute of Science and Technology in Oncogenomics (INCITO), Sao Paulo, Brazil., Torrezan GT; Genomics and Molecular Biology Group, International Center of Research CIPE, A.C. Camargo Cancer Center, Sao Paulo, Brazil.; National Institute of Science and Technology in Oncogenomics (INCITO), Sao Paulo, Brazil., Wolff BM; Cytogenomic Laboratory, Department of Pathology, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil., Kulikowski LD; Cytogenomic Laboratory, Department of Pathology, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil., Costa FD; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.; Dasa Laboratories, Sao Paulo, Brazil., Aldape K; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Ida CM; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.

Publikováno v: Journal of neuropathology and experimental neurology [J Neuropathol Exp Neurol] 2024 Apr 19; Vol. 83 (5), pp. 357-364.

A Case Study of a Rare Undifferentiated Spindle Cell Sarcoma of the Penis: Establishment and Characterization of Patient-Derived Models.

Autor: Sousa ACDS; Clinical and Functional Genomics Group, A.C. Camargo Cancer Center, Sao Paulo 01508-010, Brazil.; National Institute of Science and Technology in Oncogenomics and Therapeutic Innovation, Sao Paulo 01508-010, Brazil.; Graduate Program of A.C.Camargo Cancer Center, Sao Paulo 01508-020, Brazil., Fernandes BLNC; Sao Lucas Hospital Rede D'Or, Sergipe Emergency Hospital Oncology Service, Aracaju 49081-060, Brazil., da Silva JPA; Real Institute of Oncological Surgery, Real Hospital Português, Recife 52010-075, Brazil., Stevanato Filho PR; Reference Center in Sarcoma, A.C. Camargo Cancer Center, Sao Paulo 01509-900, Brazil., Coimbra LBCT; Clinical and Functional Genomics Group, A.C. Camargo Cancer Center, Sao Paulo 01508-010, Brazil.; National Institute of Science and Technology in Oncogenomics and Therapeutic Innovation, Sao Paulo 01508-010, Brazil., de Oliveira Beserra A; Clinical and Functional Genomics Group, A.C. Camargo Cancer Center, Sao Paulo 01508-010, Brazil.; National Institute of Science and Technology in Oncogenomics and Therapeutic Innovation, Sao Paulo 01508-010, Brazil.; Graduate Program of A.C.Camargo Cancer Center, Sao Paulo 01508-020, Brazil., Alvarenga AL; Clinical and Functional Genomics Group, A.C. Camargo Cancer Center, Sao Paulo 01508-010, Brazil.; National Institute of Science and Technology in Oncogenomics and Therapeutic Innovation, Sao Paulo 01508-010, Brazil., Maida G; Clinical and Functional Genomics Group, A.C. Camargo Cancer Center, Sao Paulo 01508-010, Brazil.; National Institute of Science and Technology in Oncogenomics and Therapeutic Innovation, Sao Paulo 01508-010, Brazil., Guimaraes CT; Clinical and Functional Genomics Group, A.C. Camargo Cancer Center, Sao Paulo 01508-010, Brazil.; National Institute of Science and Technology in Oncogenomics and Therapeutic Innovation, Sao Paulo 01508-010, Brazil., Nakamuta IM; Graduate Program of A.C.Camargo Cancer Center, Sao Paulo 01508-020, Brazil.; Heart Institute of School of Medicine, University of Sao Paulo, Sao Paulo 05403-900, Brazil., Marchi FA; Center for Translational Research in Oncology, Cancer Institute of the State of Sao Paulo (ICESP), Clinical Hospital of the University of Sao Paulo Medical School (HCFMUSP), Sao Paulo 01246-000, Brazil., Alves C; Ziel Biosciences, Department of Translational Research, Porto Alegre 90050-170, Brazil., Lichtenfels M; Ziel Biosciences, Department of Translational Research, Porto Alegre 90050-170, Brazil., de Farias CB; Ziel Biosciences, Department of Translational Research, Porto Alegre 90050-170, Brazil., Kupper BEC; Reference Center in Sarcoma, A.C. Camargo Cancer Center, Sao Paulo 01509-900, Brazil., Costa FD; Reference Center in Sarcoma, A.C. Camargo Cancer Center, Sao Paulo 01509-900, Brazil.; Anatomic Pathology Department, A.C. Camargo Cancer Center, Sao Paulo 01509-900, Brazil., de Mello CAL; Reference Center in Sarcoma, A.C. Camargo Cancer Center, Sao Paulo 01509-900, Brazil., Carraro DM; Clinical and Functional Genomics Group, A.C. Camargo Cancer Center, Sao Paulo 01508-010, Brazil.; National Institute of Science and Technology in Oncogenomics and Therapeutic Innovation, Sao Paulo 01508-010, Brazil., Torrezan GT; Clinical and Functional Genomics Group, A.C. Camargo Cancer Center, Sao Paulo 01508-010, Brazil.; National Institute of Science and Technology in Oncogenomics and Therapeutic Innovation, Sao Paulo 01508-010, Brazil., Lopes A; Reference Center in Sarcoma, A.C. Camargo Cancer Center, Sao Paulo 01509-900, Brazil., Dos Santos TG; Clinical and Functional Genomics Group, A.C. Camargo Cancer Center, Sao Paulo 01508-010, Brazil.; National Institute of Science and Technology in Oncogenomics and Therapeutic Innovation, Sao Paulo 01508-010, Brazil.

Publikováno v: Genes [Genes (Basel)] 2024 Mar 28; Vol. 15 (4). Date of Electronic Publication: 2024 Mar 28.